All In Biotech

Free tool

FAERS Monitor: Imodium Multi-Symptom Relief

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021140 or its brand name (Imodium Multi-Symptom Relief, Loperamide Hydrochloride, Simethicone). Reports on generic versions are filed under their own applications.

Reports

32,268

Serious

18,867

58% of reports

Hospitalization

11,312

Death reported

2,549

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea6,587
  • drug ineffective3,174
  • nausea3,134
  • fatigue2,654
  • off label use2,287
  • vomiting2,148
  • constipation1,816
  • weight decreased1,538
  • incorrect dose administered1,429
  • headache1,398
  • dyspnoea1,388
  • abdominal pain1,362
  • asthenia1,334
  • dehydration1,245
  • dizziness1,245

Reports by year received

View as table
YearReports
2004255
2005303
2006321
2007354
2008410
2009424
2010473
2011671
2012874
2013770
2014970
20154,439
20161,910
20172,173
20182,311
20191,989
20202,173
20212,035
20222,152
20232,354
20241,928
20251,862
20261,114

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,891 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
diarrhoeaSignal6,5876.76.632,675
dehydrationSignal1,2456.15.85,326
constipationSignal1,8165.55.26,634
incorrect dose administeredSignal1,4294.13.93,362
abdominal painSignal1,3623.83.62,864
weight decreasedSignal1,5383.63.42,916
vomitingSignal2,1483.02.92,889
nauseaSignal3,1342.62.53,157
astheniaSignal1,3342.32.21,012
fatigueSignal2,6542.22.11,854
off label use2,2871.71.6692
dizziness1,2451.61.5308
dyspnoea1,3881.61.5319
drug ineffective3,1741.61.5701
headache1,3981.51.4204

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.